Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards
Diabetes Care
.
2021 Jun;44(6):e121-e123.
doi: 10.2337/dc20-3063.
Epub 2021 May 20.
Authors
Halis K Akturk
1
,
Shivani Agarwal
2
3
,
Lilian Hoffecker
4
,
Viral N Shah
5
Affiliations
1
Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO halis.akturk@cuanschutz.edu.
2
Fleischer Center for Diabetes and Metabolism, Montefiore Medical Center, Bronx, NY.
3
Center for Diabetes Translation Research, Albert Einstein College of Medicine, Bronx, NY.
4
Strauss Health Sciences Library, University of Colorado Anschutz Medical Campus, Aurora, CO.
5
Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO.
PMID:
34016613
PMCID:
PMC8247501
DOI:
10.2337/dc20-3063
No abstract available
Publication types
Letter
MeSH terms
Diabetes Mellitus, Type 1* / therapy
Ethnicity
Humans
Racial Groups
Randomized Controlled Trials as Topic
Grants and funding
K23 DK115896/DK/NIDDK NIH HHS/United States
P30 DK111022/DK/NIDDK NIH HHS/United States